doi: 10.1161/CIRCULATIONAHA.106.678326
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:1725-1735.)
© 2007 American Heart Association, Inc.
Cardiovascular Involvement in General Medical Conditions |
Thyroid Disease and the Heart
From the Department of Medicine and the Feinstein Institute for Medical Research (I.K., S.D.), North Shore University Hospital, Manhasset, and the Departments of Medicine (I.K., S.D.) and Cell Biology (I.K.), New York University School of Medicine, New York, NY.
Correspondence to Dr Irwin Klein, North Shore University Hospital, 350 Community Dr, Manhasset, NY 11030. E-mail iklein{at}nshs.edu
The cardiovascular signs and symptoms of thyroid disease are some of the most profound and clinically relevant findings that accompany both hyperthyroidism and hypothyroidism. On the basis of the understanding of the cellular mechanisms of thyroid hormone action on the heart and cardiovascular system, it is possible to explain the changes in cardiac output, cardiac contractility, blood pressure, vascular resistance, and rhythm disturbances that result from thyroid dysfunction. The importance of the recognition of the effects of thyroid disease on the heart also derives from the observation that restoration of normal thyroid function most often reverses the abnormal cardiovascular hemodynamics. In the present review, we discuss the appropriate thyroid function tests to establish a suspected diagnosis as well as the treatment modalities necessary to restore patients to a euthyroid state. We also review the alterations in thyroid hormone metabolism that accompany chronic congestive heart failure and the approach to the management of patients with amiodarone-induced alterations in thyroid function tests.
Key Words: hyperthyroidism • hypothyroidism • heart failure • tachyarrhythmias • thyroid
This article has been cited by other articles:
 |
|
 |
|
  N. Tanabe, H. Iso, N. Seki, H. Suzuki, H. Yatsuya, H. Toyoshima, A. Tamakoshi, and for the JACC Study Group Daytime napping and mortality, with a special reference to cardiovascular disease: the JACC study Int. J. Epidemiol., November 9, 2009; (2009) dyp327v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sarafoff, D. M. Baur, J. Gaa, and N. von Beckerath Recurrent Syncope Due to Torsades de Pointes in a 41-Year-Old Woman With an Empty Sella, Anterior Pituitary Insufficiency, and a Long-QT Interval Circulation, October 6, 2009; 120(14): e127 - e129. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stavrakis, X. Yu, E. Patterson, S. Huang, S. R. Hamlett, L. Chalmers, R. Pappy, M. W. Cunningham, S. A. Morshed, T. F. Davies, et al. Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1309 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Henderson, S. Danzi, J. T. Paul, G. Leya, I. Klein, and A. M. Samarel Physiological Replacement of T3 Improves Left Ventricular Function in an Animal Model of Myocardial Infarction-Induced Congestive Heart Failure Circ Heart Fail, May 1, 2009; 2(3): 243 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Desai, S. Cheng, A. Nohria, F. Halperin, and R. P. Giugliano When Past Is Prologue N. Engl. J. Med., March 5, 2009; 360(10): 1016 - 1022. [Full Text] [PDF]
|
|
|
|
|
|
L. Sacca Heart Failure as a Multiple Hormonal Deficiency Syndrome Circ Heart Fail, March 1, 2009; 2(2): 151 - 156. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Napoli, V. Apuzzi, G. Bosso, C. D'Anna, A. De Sena, C. Pirozzi, A. Marano, G. A. Lupoli, G. Cudemo, U. Oliviero, et al. Recombinant Human Thyrotropin Enhances Endothelial-Mediated Vasodilation of Conduit Arteries J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 1012 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Rodondi, D. C. Bauer, A. R. Cappola, J. Cornuz, J. Robbins, L. P. Fried, P. W. Ladenson, E. Vittinghoff, J. S. Gottdiener, and A. B. Newman Subclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure: The Cardiovascular Health Study J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1152 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Biondi Should we treat all subjects with subclinical thyroid disease the same way? Eur. J. Endocrinol., September 1, 2008; 159(3): 343 - 345. [Full Text] [PDF]
|
|
|
|
|
|
M. Kars, V. Delgado, E. R. Holman, R. A. Feelders, J. W. A. Smit, J. A. Romijn, J. J. Bax, and A. M. Pereira Aortic Valve Calcification and Mild Tricuspid Regurgitation But No Clinical Heart Disease after 8 Years of Dopamine Agonist Therapy for Prolactinoma J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3348 - 3356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Ladenson Cardiovascular Consequences of Subclinical Thyroid Dysfunction: More Smoke but No Fire Ann Intern Med, June 3, 2008; 148(11): 880 - 881. [Full Text] [PDF]
|
|
|
|
 |
|
 B. O. Asvold, T. Bjoro, T. I. L. Nilsen, D. Gunnell, and L. J. Vatten Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study Arch Intern Med, April 28, 2008; 168(8): 855 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Klein and S. Danzi Thyroid Hormone Treatment to Mend a Broken Heart J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1172 - 1174. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Vergaro and M. Emdin Cardiac angiotensin receptor expression in hypothyroidism: back to fetal gene programme? J. Physiol., January 1, 2008; 586(1): 7 - 8. [Full Text] [PDF]
|
|